JOSHA
Donate
Author

Roland Mertelsmann

Albert-Ludwigs Universität · Journal of Science, Humanities and Arts (JOSHA) · Uniklinik Freiburg, Med 1 · University of Freiburg · Journal of Science, Humanities and Arts (JOSHA) · BioThera-Roland Mertelsmann Foundation

90 Publications

Informing patients of relevant health information and innovations: patient recall or annual physical?
Humanities, Social Sciences and Law
| DOI: 10.17160/josha.5.6.455

Informing patients of relevant health information and innovations: patient recall or annual physical?

F

Felicitas Holzer, Ignacio Mastroleo, Roland Mertelsmann

University of Buenos Aires

Recently the NEJM published an interesting debate on the value of the annual physical (also known as “periodic health examination”) (Goroll 2015). “Today, because of the rapid growth of medical…

1,718
2,863
PDF
1st Freiburg,Germany – Mendoza, Argentina Symposium on Translational Medicine
News and Views
| DOI: 10.17160/josha.5.5.423

1st Freiburg,Germany – Mendoza, Argentina Symposium on Translational Medicine

A

Astrid Schmidt, Israel Vega, Birke Ahlfeldt, Roland Mertelsmann, Jürgen Rühe, Hans-Peter Deigner, María Colombo, Felicitas Holzer, Sean Patterson, Emiliano Diez

Facultad de Ciencias Médicas Universidad Nacional de Cuyo

The initiative for organizing this symposium arose a few months ago, during the visit of Prof. Borner and Prof. Mertelsmann. It was supported by the German Consulate of Mendoza, particularly…

1,820
3,848
PDF
JOSHA’S CRITICAL REVIEW OF “Efficacy of Larotrectinib in TRK Fusion– Positive Cancers in Adults and Children”
Life Sciences
| DOI: 10.17160/josha.5.4.427

JOSHA’S CRITICAL REVIEW OF “Efficacy of Larotrectinib in TRK Fusion– Positive Cancers in Adults and Children”

R

Roland Mertelsmann, Gerhard Steinmann

Albert-Ludwigs Universität

JOSHA´S CONCLUSION. IMPORTANT PROGRESS; ESPECIALLY FOR PATIENTS WITH SARCOMAS FOR WHOM VERY FEW TREATMENT ALTERNATIVES EXIST. TRK-FUSION TESTING SHOULD BECOME ROUTINE IN PATIENTS WITH SARCOMA AND SELECTED PATIENTS WITH OTHER…

1,876
3,332
PDF
El IMBS “Diploma of Advanced Studies” Escuela de Invierno en Ciencias Biomédicas Freiburg 2018-19. Fecha límite de aplicación: 31 de julio 2018
Life Sciences
| DOI: 10.17160/josha.5.4.430

El IMBS “Diploma of Advanced Studies” Escuela de Invierno en Ciencias Biomédicas Freiburg 2018-19. Fecha límite de aplicación: 31 de julio 2018

R

Roland Mertelsmann, Bärbel Schätzle, Christoph Borner

Albert-Ludwigs Universität

The Winter School of Biomedical Sciences is a 5 months international program at the University of Freiburg. It is designed as an intensive time of studies and research with specific…

1,740
2,948
PDF
JOSHA’S CRITICAL REVIEW OF “GENE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA” BY A.A. Thompson et al. N Engl J Med 2018; 378:1479- 1493.
Life Sciences
| DOI: 10.17160/josha.5.4.426

JOSHA’S CRITICAL REVIEW OF “GENE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA” BY A.A. Thompson et al. N Engl J Med 2018; 378:1479- 1493.

R

Roland Mertelsmann, Gerhard Steinmann

Albert-Ludwigs Universität

THESE INTERIM RESULTS OF TWO PHASE I/II TRIALS ARE REMARKABLE. THOMPSON AND COLLEAGUES DEMONSTRATE THE PROGRESS OF CLINICAL GENE THERAPY FOR MONOGENETIC DISEASES WITH A MEDIAN OBSERVATION TIME OF 26…

1,838
3,296
PDF
DEMETRIOS PRIZE 2018
News and Views
| DOI: 10.17160/josha.5.3.419

DEMETRIOS PRIZE 2018

R

Roland Mertelsmann

Uniklinik Freiburg, Med 1

The JOSHA Team is very pleased to share with you information about the IASHA Demetrios Prize 2018. For the categories BACHELOR, MASTER and DOCTORAL thesis the International Academy of Science,…

1,923
3,037
PDF